A STUDY OF THE SAFETY, TOLERABILITY, AND ANTIRETROVIRAL ACTIVITY OF RALTEGRAVIR (MK-0518) IN COMBINATION WITH OTHER ANTIRETROVIRAL THERAPIES IN RUSSIAN CHILDREN AND ADOLESCENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) (MK-0518-248):